NCT07390604Completed
Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )
Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease Clinical and Biological Outcomes in Patients at Cardiovascular and Thromboembolic Risk
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
Lipoprotein-apheresis DFPP has been performed in patients with Lp(a) levels greater than 125 nmol/L. In this report, data will be presented on five hemodialysis patients with significantly elevated Lp(a) levels (\>200 nmol/L) who had a history of cardiovascular disease and notable thromboembolic events.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 5 (actual)
- First submitted
- 14 Jan 2026
- Start date
- 1 Jul 2025
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Centre Hospitalier Régional Metz-Thionville
- Diseases
- Chronic kidney disease
- NCT number
- NCT07390604
What you commit to
- Study type: Observational
- Participants enrolled: 5
- From 1 Jul 2025 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- -Patients with progressive, active disease, presenting with severe general deterioration and a limited life expectancy
- Patients presenting with acute kidney diseases.
Other
- Patients presenting with hemodynamic instability
Who the study is looking for
- Chronic hemodialysis patients with elevated Lp(a) levels (\>200 nmol/L) and a history of cardiovascular disease and/or thromboembolic events who underwent DFPP sessions as part of their management
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHR Metz-Thionville/Hopital de Mercy Coordinator of this site? Confirm its status | Metz | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.